Nasdaq

ArriVent BioPharma, Inc.

Pharmaceutical PreparationsCIK 0001868279Newtown Square, PennsylvaniaFilings at SEC EDGAR

At a glance

Most recent filing on November 2, 2026 — an option exercise by LaChapelle Robin on Oct 30, 2026.

We hold 10 Form 4 lines, going back to November 2, 2026.

Insider trades

5 of 10 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 10. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

LaChapelle Robin Chief Operating Officer
no market priceOption exercise
TradedOct 30, 2026FiledNov 2, 2026
LaChapelle Robin Chief Operating Officer
no market priceOption exercise
TradedOct 30, 2026FiledNov 2, 2026
LaChapelle Robin Chief Operating Officer
no market priceOption exercise
TradedOct 30, 2026FiledNov 2, 2026
LaChapelle Robin Chief Operating Officer
no market priceOption exercise
TradedOct 30, 2026FiledNov 2, 2026
LaChapelle Robin Chief Operating Officer
no market priceOption exercise
TradedOct 30, 2026FiledNov 2, 2026